Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002265201 | SCV002546839 | uncertain significance | not provided | 2022-01-10 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002265201 | SCV003019235 | pathogenic | not provided | 2022-06-24 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with UPB1-related conditions. This variant is present in population databases (rs755693951, gnomAD 0.05%). This sequence change creates a premature translational stop signal (p.Ala120Hisfs*64) in the UPB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in UPB1 are known to be pathogenic (PMID: 15385443, 22525402). |